• Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9
  • Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9
  • Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9
  • Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9
  • Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9
  • Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9

Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: Powder
Purity: >99%
Samples:
US$ 300/BAG 1 BAG(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2023

Suppliers with verified business licenses

Manufacturer/Factory
  • Overview
  • Product Description
  • Product Specificaiton
  • Function & Application
  • OEM Service
  • Recommend products
  • Packaging & Shipping
  • Company Profile
  • FAQ
Overview

Basic Info.

Model NO.
HZ-Favipiravir
Grade
Healethcare Products
CAS No.
259793-96-9
Appearance
White Crystal Powder
Molecular Formula
C5h4fn3o2
Assay
99%
Test Method
HPLC
Molrcular Weight
157.1
Application
Pharmaceutical Intermediate Antiviral
Shelf Life
2 Years
OEM
Customization Label and Packing Bottles
Transport Package
Bottle and Carton
Specification
500mg/capsule
Trademark
Customzied
Origin
China
HS Code
2020032003
Production Capacity
5000kg/Month

Product Description

Product Description

Favipiravir, chemically known as 6-fluoro-3-hydroxypyrazine-2-carboxamide, is a new broad-spectrum antiviral drug targeting RNA-dependent RNA polymerase (RdRp) developed by Toyama Chemical Pharmaceutical Company in Japan, approved for marketing in Japan in March 2014 for the treatment of novel and recurrent influenza. Studies have shown that in addition to influenza virus, favipiravir also shows good antiviral activity against a variety of RNA viruses, such as Ebola virus, arenavirus, Bunya virus, rabies virus, etc. The latest studies have shown that favipiravir has a certain inhibitory effect on novel coronavirus pneumonia.

Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9
Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9

 

Product Specificaiton

Product Name: Favipiravir Assay:  99% 
Standard Enterprise standard Appearance: White Crystalline Powder
CAS NO 259793-96-9 EINECS 1533716-785-6
Minimum  order  quantity 500g Packing: 1kg/aluminum foil bag; 25kg/drum
Density 1.6±0.1 g/cm3
 
Boiling Point 552.6±50.0 °C at 760 mmHg
 
Molecular Formula C5H4FN3O2
 
Molecular Weight 157.103
 
Flash Point 288.0±30.1 °C
 
Exact Mass 157.028748
 
PSA 88.84000
 
LogP 0.78
 
Vapour Pressure 0.0±1.5 mmHg at 25°C
 
Index of Refraction 1.600
>Click here to get more information 
 

Function & Application

Function:
Favipiravir is a broad-spectrum antiviral drug that was cleared by the Drugs Controller General of India (DCGI) last week for "emergency restricted" use among C ovid 19 patients. Glenmark will sell the generic favipiravir under the brand name FabiFlu.
Favipiravir was originally developed in the late 1990s by a company that was later purchased by the Japanese firm Fujifilm as part of its transition from the photo business to healthcare. After being tested against a range of viruses, the drug was approved in Japan in 2014 for emergency use against flu epidemics or to treat new strains of influenza.

Favipiravir,  6-fluoro-3-hydroxypyrazine-2-carboxamide, is a new broad-spectrum antiviral drug targeting RNA-dependent RNA polymerase (RdRp). It was approved for marketing in Japan in March 2014 for the treatment of new and recurrent influenza. During the outbreak of the new coronavirus, the results of the Phase I clinical study of the drug published in March 2020 showed that the drug may have the effect of speeding up virus clearance to alleviate the progress of new coronavirus pneumonia.

Favipiravir can be used for antiviral treatment of influenza A and B. Studies have shown that in addition to influenza virus, the drug also exhibits good antiviral activity against a variety of RNA viruses, such as Ebola virus, arena virus, Bunia virus, and rabies virus.
Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9Application:
Favipiravir can be used for antiviral therapy for influenza A and B. Studies have shown that in addition to influenza virus, the drug also shows good antiviral activity against a variety of RNA viruses, such as Ebola virus, arenavirus, Bunya virus, rabies virus, etc.

OEM Service

As a professional health product supplier, we can customize Favipiravir powder with different packing, Favipiravir capusel with different bottles according to your formula and requests.

Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9
Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9

Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9
Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9                                                                   >Click here to get more information 

Recommend products

Fladrafinil ≥98.0% HPLC 90212-80-9
Picamilon (Sodium) ≥98%~101%Titration 62936-56-5
Sunifiram ≥99.5% HPLC 314728-85-3
Unifiram ≥99.0% HPLC 272786-64-8
Tianeptine acid ≥99.0% HPLC 66981-73-5
Tianeptine sodium ≥99.0% HPLC 30123-17-2
Tianeptine Hemisukfate Monohydrate ≥98.0%~102.0% HPLC 66981-73-5
Galantamine Hydrobromide ≥99.0% HPLC 69353-21-5
Galanthamine ≥99.0% HPLC 357-70-0
Huperzine A  ≥1.0% and 99%  HPLC 102518-79-6
NSI-189 Freebase ≥99.0% HPLC 1270138-40-3
NSI-189 Phosphate ≥99.0% HPLC 1270138-41-4
PRL-8-53  ≥99.0% HPLC 51352-87-5
agomelatine ≥99.0% HPLC 138112-76-2
5a hydroxy laxogenin ≥99.0% HPLC 56786-63-1
Vincamine ≥99.0% HPLC 1617-90-9
Centrophenoxine ≥99.0% HPLC 3685-84-5
N-coumaroyldopamine ≥99.0% HPLC 103188-46-1
N-caffeoyldopamine ≥99.0% HPLC 103188-49-4

Packaging & Shipping

Goods weight
 
Packing
 
Shipping method
 
Lead-time
 
1-50kg
 
Below 5kg Use Foil bag;5-25kg use two layer PP bag,then into master carton or cardboard drum
 
International express
 
1~3 days after your payment
100-200kg
 
25kg/drum,use two layer PP bag,then into cardboard drum
 
Air shipping
Sea Shipping
3~5 days after your payment
Over 500kg
 
25kg/drum,use two layer PP bag,then into cardboard drum
 
Sea shipping
 
5~10 days after your payment

 

Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9

Company Profile

Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9Bulk Price Pharmaceutical Intermediate Antiviral API 99% Favipiravir Powder CAS 259793-96-9

FAQ

Q1: Can I get some free sample?

A: Yes, we offer free sample to client and you only need to pay the fright.

Q2: Could you accept customzied order? 
A: Yes, we accept customized service according your requests, you can communicate with sales manager to know more details.

Q3: When the product can be delivery? 
A: We normal delivery the product within 2-4 days, the more details will inform to you by our sales manager. 

Q4: Could i get certificate of analysis (COA) about product?
A: Of course, please contact us to get it. 

 
Q5: Is there any discount? 
A:Yes, we can give you discount, but it depends on your quantity.

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now